Gut microbiota‐derived synbiotic formula (SIM01) as a novel

Gut microbiota‐derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID‐19: An open‐label pilot study - Zhang - 2022 - Journal of Gastroenterology and Hepatology - Wiley Online Library

Nutrients, Free Full-Text

Synbiotic formula shows promise in reducing long COVID symptoms

Zhang: Gut microbiota-derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID-19: An open-label pilot study [Probiotics]

The association between macronutrient intakes and coronavirus disease 2019 (COVID-19) in an Iranian population: applying a dynamical system model, Journal of Health, Population and Nutrition

IJMS, Free Full-Text

Gut microbiota‐derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID‐19: An open‐label pilot study - Zhang - 2022 - Journal of Gastroenterology and Hepatology - Wiley Online Library

Siew NG, Professor (Full), MBBS (Lon), FRCP (Lond, Edin), PhD (Lond), FHKCP, FHKAM (Med), The Chinese University of Hong Kong, Hong Kong, CUHK, Department of Medicine and Therapeutics

Lactobacillus plantarum 69-2 Combined with Galacto-Oligosaccharides Alleviates d-Galactose-Induced Aging by Regulating the AMPK/SIRT1 Signaling Pathway and Gut Microbiota in Mice

Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications

The Role of the Gut-Lung Axis in COVID-19 Infections and Its Modulation to Improve Clinical Outcomes